Contact Us

Industries

Food and Beverage

Why this Industry?

Pharma operates under intense regulatory pressure — FDA, WHO, EMA, DSCSA/EU FMD — where the cost of a compliance finding is high and paper-based, manual processes are a direct source of audit risk. This is our most deeply sourced industry vertical, reflecting a dedicated ACTIN pharma practice. 

This depth of account experience, spanning quality, OT modernisation, and compliance across multiple Indian pharma manufacturers, is the foundation we intend to extend into GCC pharma manufacturing, where FDA/WHO-aligned compliance regimes mirror what we already support. NOTE FOR REVIEW: no specific GCC pharma deals, timelines, or client names are claimed here — none exist yet. 

Four Core Pillars Of Pharma Digital Transformation

Digital Quality & Compliance (QMS)

Paperless quality management with AI-assisted CAPA workflows and ALCOA+-aligned, blockchain-backed audit trails.

Smart & Connected Manufacturing

IIoT and MES++ enabling paperless electronic batch records (eBatches).

Integrated Supply Chain & Serialization

DSCSA/EU FMD track-and-trace compliance, with cold-chain visibility.

R&D & Lifecycle Acceleration

PLM combined with AI to speed development and lifecycle management.

Key Differentiators For Pharma 

  • Compliance-by-Design — regulatory requirements engineered into the solution from the start, not bolted on afterward. 
  • Pre-Built Pharma Accelerators — ready-made components rather than a from-scratch build for common pharma requirements. 
  • OT/IT Convergence Expertise — the same shop-floor-to-cloud discipline ACTIN applies across manufacturing, tuned for GxP environments. 
  • Strategic Partnership — engagement structured as an ongoing partnership rather than a single project. 

Solution Portfolio 

  • OT Modernization Platform — modernizing operational technology across plant control and monitoring systems. 
  • Asset Performance Monitoring (APM) — condition and performance visibility on critical manufacturing assets. 
  • Machine and Manufacturing Control Platform (MCP) — control-layer platform spanning machine and manufacturing operations. 
  • Centralized Data Repository (CDR) — a single, governed data foundation across plants and systems. 

Ot Maturity Roadmap 

A six-level maturity model — Level 0 Ad-hoc through Level 5 Autonomous — governed through a three-tier structure (Enterprise OT Council, Regional/BU Committees, Plant-Site OT Teams). The pharma-specific target: Level 3 as the minimum bar, Level 4 as best practice, Level 5 as the future state. 

Engagement Model — The Compliance Gap Assessment

A consultant-led review of current processes, data integrity, and digital maturity against FDA/WHO standards — the starting point for ACTIN’s Pharma 4.0 offering: paperless QMS with ALCOA+ audit trails, AI-powered CAPA, eDMS & LMS for audit-readiness, and end-to-end serialization for DSCSA/EU FMD compliance. EnviroConnect (*powered by AIPL) extends this into cleanroom environmental monitoring (particle counts, temperature, humidity) alongside industrial emissions — see Solutions → EnviroConnect.

Case Studies

Case Study — OT Modernization Program Deployment

A leading Indian pharmaceutical manufacturer, multi-plant operation 

  • Deployed an OT modernization program across multiple manufacturing plants. 
  • Outcomes: improved real-time asset visibility, reduced unplanned downtime, and a standardized data foundation across sites. 

Multi-site OT infrastructure upgrade program 

  • 6 CFAST cloning projects completed, preserving legacy control logic while removing single points of hardware failure. 
  • 6 IPC (Industrial PC) virtualizations completed, reducing dependency on aging, hard-to-source hardware. 
  • 2 complete and 4 in-progress upgrades to a web-based server and Android-tablet operator interface. 
  • Outcome: recovery time from a control-system failure brought down to under 5 minutes. 

Another leading Indian pharmaceutical manufacturer, 5 manufacturing locations 

  • Ongoing OT management with 5 onsite L1 engineers, backed by L2/L3 remote support. 
  • Outcome: consistent, standardized OT support coverage across a geographically distributed plant footprint. 

A leading biotechnology company 

  • Compared a modernized, web-based control system against a traditional IPC + SCADA setup across process parameters including accessibility, redundancy, upgrade path, and operator experience. 
  • Outcome: a more accessible, remotely supportable control platform for bioreactor operations, without the hardware lock-in of the traditional setup. 

Ready to Rewire Your Enterprise?

Start Your Digital Lean Journey